

Presentation of the migraine-histamine hypothesis
Presentation of the hypothesis linking histamine to migraine processes, among the...

First evidence of "DAO-migraine"
Presentation of the results of the MigraDAO1 study at the International Migraine Day, held in...

Vienna, Annual Congress of Neurology
Awarded 2nd Prize at the 6th World Congress on Controversies in Neurology (CONy).



Leipzig, Germany
Publication of the study linking migraine, due to DAO Deficiency, with gastrointestinal symptoms.

Vienna, XXI World Congress of Neurology (WCN)
Presentation of the results of the MigraDAO2.



New clinical trial study.
DAO treatment in patients with chronic non-allergic rhinitis.

New publication on migraine
Low serum levels of Diamine Oxidase (DAO) in migraine patients.

Clinical Nutrition Research
Publication of the DAO-migraine studies in the journal Clinical Nutrition Research.

European Commission
The active ingredient DAO is authorized by the European Commission according to Regulation 2018/1023, as...



First animal DAO production plant
Inauguration of the first DAO production plant of animal origin in Tarragona.


DAO Genetic Study
Presentation of the first study of the ACO1 gene coding for DAO synthesis.


European Commission
European Commission approves new pharmaceutical forms (tablets and capsules) of DAO enzyme.

AB Biotek Acquires Spanish Biomedical DR Healthcare
Respective leaders in fermentation science and DAO-based medical nutrition join together to focus on innovative...

International Congress of DAO Deficiency 2021
You are invited to map a new future in managing DAO Deficiency attending the International...

Vegetable DAO production plant
Inauguration of the DAO Vegetal production plant in Tarragona.

2nd International Congress on DAO Deficiency
DR Healthcare, together with the International Society for DAO Deficiency, is organizing the second...


Presentation of the migraine-histamine hypothesis
Presentation of the hypothesis linking histamine to migraine processes, among the...

First evidence of "DAO-migraine"
Presentation of the results of the MigraDAO1 study at the International Migraine Day, held in...

Vienna, Annual Congress of Neurology
Awarded 2nd Prize at the 6th World Congress on Controversies in Neurology (CONy).



Leipzig, Germany
Publication of the study linking migraine, due to DAO Deficiency, with gastrointestinal symptoms.

Vienna, XXI World Congress of Neurology (WCN)
Presentation of the results of the MigraDAO2.



New clinical trial study.
DAO treatment in patients with chronic non-allergic rhinitis.

New publication on migraine
Low serum levels of Diamine Oxidase (DAO) in migraine patients.

Clinical Nutrition Research
Publication of the DAO-migraine studies in the journal Clinical Nutrition Research.

European Commission
The active ingredient DAO is authorized by the European Commission according to Regulation 2018/1023, as...



First animal DAO production plant
Inauguration of the first DAO production plant of animal origin in Tarragona.


DAO Genetic Study
Presentation of the first study of the ACO1 gene coding for DAO synthesis.


European Commission
European Commission approves new pharmaceutical forms (tablets and capsules) of DAO enzyme.

AB Biotek Acquires Spanish Biomedical DR Healthcare
Respective leaders in fermentation science and DAO-based medical nutrition join together to focus on innovative...

International Congress of DAO Deficiency 2021
You are invited to map a new future in managing DAO Deficiency attending the International...

Vegetable DAO production plant
Inauguration of the DAO Vegetal production plant in Tarragona.

2nd International Congress on DAO Deficiency
DR Healthcare, together with the International Society for DAO Deficiency, is organizing the second...